JM
James M. Wilson, M.D., Ph.D.
Scientific Founder (Professor & Director, Gene Therapy Program, University of Pennsylvania)
iECURERoles
Therapeutic Areas
iECURE Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ECUR-506 | Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency | Phase 1/2 |